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swept across the globe causing hundreds of
thousands of deaths, shutting down econo-
mies, closing borders and wreaking havoc on
an unprecedented scale. It has strained
healthcare services and personnel to the brink
in many regions and will certainly deeply mark
medical research both in the short and long-
term.
Prior to the COVID pandemic, virology
research (including influenza) represented less
than 2% of all biomedical research. However,
the number of laboratories and investigators
that have pivoted to address COVID related
research questions is astonishing, likely
comprising 10e20% of current biomedical
investigation, showing the incredible adapt-
ability of the research community [1]. The
multinational support rapidly infused for
COVID-19 research is in the billions of euros
[2]. The sharing of research findings and
research data has never been as rapid and
efficient [3]. The crisis has also brought dis-
ease, health, and healthcare back to the
forefront of societal issues, and will have a
lasting impact on public spending. However,
with all this optimism and focus, there is a
downside.
To begin, the COVID-19 crisis has led to a
massive influx of publications. Not only are
specialty journals being flooded with sub-
missions by authors being unwittingly granted
much needed writing time, but publications on
COVID have literally inundated us. More than
20,000 papers have been published since
December 2019, many in prestigious journals.
There are also an increasing number of studies
being uploaded to preprint servers, such as
BioRxiv, for rapid dissemination prior to any
peer review. However, we cannot assume that
the time and quality available for peer review
is able to keep pace with the explosion of
publication. There is need for increased
caution in the wake of this massive influx of
submissions, especially since we are increas-
ingly seeing these results being picked up byrper L et al., The impact of COVID-19 on research, Jou
rol.2020.07.002
ediatric Urology Company. Published by Elsevier Ltd. Athe media and diffused to a less attuned
audience. In recent weeks, several prestigious
journals, including the Lancet and the New
England Journal of Medicine, have published
retractions of earlier and potentially major
COVID-related findings [4,5]. On June 15,
2020, The New York Times highlighted poten-
tial lapses in the peer review process affecting
major scientific journals [6].
We must strive to improve scientific quality
always. The current debate over the use of
hydroxychloroquine further illustrates the
undermining of the scientific process when
faced with global desperation for ready-made
truths and solutions [4,7,8]. Science needs
time, and good science needs a lot of it for
data to grow and knowledge to evolve, but this
process is ill-prepared to handle the rush for
solutions to the COVID crises.
Moreover, just as COVID-19 has shown so-
cial, racial, and economic health disparities,
the pandemic seems also to have accentuated
existing gender inequalities within the field of
research [9]. Indeed, early analyses suggest
that female academics are publishing less and
starting fewer research projects than their
male peers. This might be an effect of the
lockdown and the fact that more women than
are men are juggling caring for families and
children despite both “working” from home
[10,11].
Travel, social, and funding restrictions will
also take a serious toll on scientific research
worldwide. Research staff and resources have
been purposely and purposefully prioritized to
COVID-19 activities above all else. Distancing
and transmission issues have caused most non-
COVID clinical research to be suspended,
causing a reduction in recruitment of research
subjects and a delay in data entry into clinical
trial databases [12]. Research-related hiring
has been suspended because of travel re-
strictions and young researchers might soon
find themselves out of a job if their subject is
not the pandemic. Indeed, though
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continuity and breadth of biomedical research, how the
economic downfall will influence government spending re-
mains to be seen. Furthermore, research funding that relies
on public fundraising is expected to drop substantially and
many researchers will see a significant decrease in funding
opportunities [13]. The global impact the crisis will have on
the economy makes it hard to imagine that future research
funding will not be substantially affected.
During this crisis, many resources were understandably
redirected toward preparing for and caring for COVID-19
patients, but the collateral damage to so many patients
with non-COVID-19 medical conditions that did not receive,
or failed to seek, treatment will surely emerge [14]. Finally,
children have also paid a high price for the redirecting of
medical resources, with delays in their medical and surgical
management, as well as vaccinations [15,16]. This may be
especially problematic when many aspects of pediatric care
is based on their developmental clock, which even the
pandemic cannot stop. Whether this was the best option
will certainly be analyzed in retrospect. Congenital anom-
alies alone account for over 400,000 deaths worldwide
every year, and inflict a considerable burden both on chil-
dren, families, and healthcare systems [17]. Thus, it is
essential that funding for medical research does not follow
the same pattern with a disproportionate decrease in
funding for non-COVID research including pediatric and
developmental urology.
COVID-19 has already changed the world, not only
because of the disease itself, but because of the long-term
effects of the world’s reaction to the pandemic. While the
pandemic may have brought with it some silver linings, it is
crucial that the scientific community conduct current and
future research broadly and openly, lest future pandemic
preparedness in research repeat the hard-fought lessons of
today.
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